Using TaqMan SNP Genotyping Assays, we evaluated FGFR2 rs2981582, TNRC9 rs3803662, TNRC9 rs12443621, and LP1 rs3817198 polymorphisms in 487 subjects, including 105 breast cancer cases and 382 controls. The gene discussed is RPLP1; the disease is breast carcinoma.